Efficacy studies of alprazolam in panic disorder

Psychopharmacology Bulletin

Volumn 34, Issue 2, 1998, Pages 191-195

  Spiegel, David A ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Alprazolam; Maintenance treatment; Panic disorder; Pharmacological treatment; Review

Indexed keywords

ALPRAZOLAM;

CANADA; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; PANIC; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ALPRAZOLAM; ANTI-ANXIETY AGENTS; CLINICAL TRIALS; HUMANS; PANIC DISORDER;

EID: 0031812489     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Ballenger, JC; Burrows, GD; DuPont, RL; Lesser, IM; Noyes, R; Pecknold, JC; Rifkin, A; Swinson, RP. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Arch. Gen. Psychiatry 45:413-422, 1988.
2. Cross-National Collaborative Panic Study, Second Phase Investigators. Drug treatment of panic disorder: Comparative efficacy of alprazolam, imipramine, and placebo. Br. J. Psychiatry 160:191-202, 1992.
3. Greenblatt, DJ; Harmatz, JS; Shader, RL Plasma alprazolam concentrations: Relation to efficacy and side effects in the treatment of panic disorder. Arch. Gen. Psychiatry 50:715-722, 1993.
4. Klerman, GL. Drug treatment of panic disorder: Reply to comment by Marks and associates. Br. J. Psychiatry 161:465-471, 1992.
5. Klerman, GL. Overview of the Cross-National Collaborative Panic Study. Arch. Gen. Psychiatry 45:407-412, 1988.